ADVICE study group, .;
(2018)
Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial.
The Lancet HIV
, 5
(10)
e553-e559.
10.1016/S2352-3018(18)30214-5.
Preview |
Text
THELANCETHIV-D-18-00209R3S.pdf - Accepted Version Download (2MB) | Preview |
Downloads since deposit
46Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
![]() |
View Item |